Company
BH Therapeutics
The Next Leap Forward in Precision Cancer Medicine
Also known as BlossomHill Therapeutics, BlossomHill Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- BlossomHill Therapeutics, Inc.
- bhtherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are on a mission to exponentially improve the number of quality years for patients. We are building upon our leadership team’s proven track record of designing and developing innovative small molecules, that aim to overcome the limitations of existing cancer therapies.
Funding snapshot
- Total raised
- $246MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $84.2M2025-11-25
Funding rounds
- Round, 2025
- $84.2M2025-11-25, SEC form D sold, 47 investors
- Round, 2023
- $88.6M2023-12-28, SEC form D sold, 44 investors
- Round, 2021
- $71M2021-03-01, SEC form D sold, 27 investors
- Round, 2020
- $2M2020-12-31, SEC form D sold, 3 investors
Loading relationship preview